AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282)

M. Piccart, Ron Epelbaum, P.F. Bruning et al.|Ghent University Academic Bibliography (Ghent University)|2000

Cited by 15